Skip to Main Content

Paper Details

Clinical Effect of Mirikizumab Treatment on Bowel Urgency in Patients with Moderately to Severely Active Ulcerative Colitis and the Clinical Relevance of Bowel Urgency Improvement for Disease Remission.
2
2023
C-reactive protein, Patients, Ulcerative Colitis, anti-IL-23 antibody, bowel, corticosteroid, fecal calprotectin, mirikizumab, p19, patients, ulcerative colitis
Author NameAffiliation
Marla C DubinskyMount Sinai Kravis Children's Hospital
  • 1 - 1

Datasets

Release 1.2